<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">EXCLI J</journal-id><journal-id journal-id-type="iso-abbrev">EXCLI J</journal-id><journal-id journal-id-type="publisher-id">EXCLI J</journal-id><journal-title-group><journal-title>EXCLI Journal</journal-title></journal-title-group><issn pub-type="epub">1611-2156</issn><publisher><publisher-name>Leibniz Research Centre for Working Environment and Human Factors</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31938027</article-id><article-id pub-id-type="pmc">6953539</article-id><article-id pub-id-type="publisher-id">2019-2062</article-id><article-id pub-id-type="doi">10.17179/excli2019-2062</article-id><article-id pub-id-type="publisher-id">Doc1094</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to the Editor</subject></subj-group></article-categories><title-group><article-title>Role of WDR5 in breast cancer prognosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Stoeber</surname><given-names>Regina</given-names></name><xref ref-type="corresp" rid="COR1">*</xref><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1">
<label>1</label>Leibniz Research Centre for Working Environment and Human Factors (IfADo)</aff><author-notes><corresp id="COR1">*To whom correspondence should be addressed: Regina Stoeber, Leibniz Research Centre for Working Environment and Human Factors (IfADo), Ardeystrasse 67, 44139 Dortmund, Germany, E-mail: <email>regina.stoeber@gmx.de</email></corresp></author-notes><pub-date pub-type="epub"><day>16</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>18</volume><fpage>1094</fpage><lpage>1096</lpage><history><date date-type="received"><day>13</day><month>12</month><year>2019</year></date><date date-type="accepted"><day>13</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Stoeber</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>) You are free to copy, distribute and transmit the work, provided the original author and source are credited.</license-p></license></permissions><self-uri xlink:type="simple" xlink:href="https://www.excli.de/vol18/Stoeber_16122019_proof.pdf">This article is available from https://www.excli.de/vol18/Stoeber_16122019_proof.pdf</self-uri></article-meta></front><body><sec><title>&#x0206f;&#x0206f;&#x0206f;</title><p><bold><italic>Dear Editor,</italic></bold></p><p>Recently, Punzi and colleagues published a study about the role of WDR5 in breast cancer metastasis (Punzi et al., 2019[<xref rid="R17" ref-type="bibr">17</xref>]). WDR5 is involved in epigenetic regulation complexes and has been reported to influence the expression of numerous genes, including N-cadherin, Snail1 and vimentin (Aho et al., 2019[<xref rid="R1" ref-type="bibr">1</xref>]; Ford and Dingwall, 2015[<xref rid="R6" ref-type="bibr">6</xref>]; Wu et al., 2011[<xref rid="R25" ref-type="bibr">25</xref>]; Chen et al., 2017[<xref rid="R5" ref-type="bibr">5</xref>]; Tan et al., 2017[<xref rid="R23" ref-type="bibr">23</xref>]). Several studies suggested WDR5 as a therapeutic target (Ye et al., 2019[<xref rid="R26" ref-type="bibr">26</xref>][<xref rid="R27" ref-type="bibr">27</xref>]; Macdonald et al., 2019[<xref rid="R14" ref-type="bibr">14</xref>]; Aho et al., 2019[<xref rid="R1" ref-type="bibr">1</xref>]; Zhang et al., 2018[<xref rid="R28" ref-type="bibr">28</xref>]; Lu et al., 2018[<xref rid="R13" ref-type="bibr">13</xref>]). In their present work, Punzi and colleagues report that downregulation of WDR5 by shRNA in breast cancer cells antagonizes the epithelial-to-mesenchymal transition through re-differentiation and reduces metastasis in a mouse model (Punzi et al., 2019[<xref rid="R17" ref-type="bibr">17</xref>]). Moreover, an association of high WDR5 expression with shorter metastasis-free survival was observed in a cohort of breast cancer patients (Punzi et al., 2019[<xref rid="R17" ref-type="bibr">17</xref>]). A further important finding of this study is that WDR5 activates TGF&#x003b2; in breast cancer and that targeting the WDR5-TGF&#x003b2; axis by a small molecular inhibitor reduces the migratory potential of breast cancer cells. Metastasis of breast cancer is a complex process (Loi et al., 2019[<xref rid="R12" ref-type="bibr">12</xref>]; von Minckwitz et al., 2019[<xref rid="R24" ref-type="bibr">24</xref>]; Gogiashvili, 2018[<xref rid="R8" ref-type="bibr">8</xref>]; Stoeber, 2017[<xref rid="R22" ref-type="bibr">22</xref>]). Besides epithelial-to-mesenchymal transition, genes involved in proliferation (Schmidt et al., 2018[<xref rid="R19" ref-type="bibr">19</xref>]), immune cell infiltration (Schmidt et al., 2012[<xref rid="R18" ref-type="bibr">18</xref>], 2018[<xref rid="R19" ref-type="bibr">19</xref>]; Heimes et al., 2017[<xref rid="R9" ref-type="bibr">9</xref>][<xref rid="R10" ref-type="bibr">10</xref>]; Godoy et al., 2014[<xref rid="R7" ref-type="bibr">7</xref>]), oxidative stress response (Cadenas et al., 2010[<xref rid="R2" ref-type="bibr">2</xref>], 2014[<xref rid="R3" ref-type="bibr">3</xref>], 2019[<xref rid="R4" ref-type="bibr">4</xref>]; Hellwig et al., 2016[<xref rid="R11" ref-type="bibr">11</xref>]) and inflammatory factors (Mattsson et al., 2015[<xref rid="R16" ref-type="bibr">16</xref>]; Sicking et al., 2014[<xref rid="R20" ref-type="bibr">20</xref>]) are of relevance; also key enzymes of phosphocholine metabolism have been shown to control breast and ovarian cancer metastasis (Marchan et al., 2017[<xref rid="R15" ref-type="bibr">15</xref>]; Stewart et al., 2012[<xref rid="R21" ref-type="bibr">21</xref>]). It will be interesting to learn in the next years, whether WDR5 targeting compounds can be identified that have a perspective to be tested in clinical studies. </p></sec></body><back><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal">
<person-group><name><surname>Aho</surname><given-names>ER</given-names></name><name><surname>Weissmiller</surname><given-names>AM</given-names></name><name><surname>Fesik</surname><given-names>SW</given-names></name><name><surname>Tansey</surname><given-names>WP</given-names></name></person-group>
<article-title>Targeting WDR5: A WINning anti-cancer strategy?</article-title>
<source>Epigenet Insights</source>
<year>2019</year>
<volume>12</volume>
<fpage>2516865719865282</fpage>
<pub-id pub-id-type="pmid">31360909</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal">
<person-group><name><surname>Cadenas</surname><given-names>C</given-names></name><name><surname>Franckenstein</surname><given-names>D</given-names></name><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Gehrmann</surname><given-names>M</given-names></name><name><surname>Hermes</surname><given-names>M</given-names></name><name><surname>Geppert</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer</article-title>
<source>Breast Cancer Res</source>
<year>2010</year>
<volume>12</volume>
<fpage>R44</fpage>
<pub-id pub-id-type="pmid">20584310</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal">
<person-group><name><surname>Cadenas</surname><given-names>C</given-names></name><name><surname>van de Sandt</surname><given-names>L</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Lohr</surname><given-names>M</given-names></name><name><surname>Hellwig</surname><given-names>B</given-names></name><name><surname>Marchan</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Loss of circadian clock gene expression is associated with tumor progression in breast cancer</article-title>
<source>Cell Cycle</source>
<year>2014</year>
<volume>13</volume>
<fpage>3282</fpage>
<lpage>3291</lpage>
<pub-id pub-id-type="pmid">25485508</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal">
<person-group><name><surname>Cadenas</surname><given-names>C</given-names></name><name><surname>Vosbeck</surname><given-names>S</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Grgas</surname><given-names>K</given-names></name><name><surname>Madjar</surname><given-names>K</given-names></name><name><surname>Hellwig</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer</article-title>
<source>Int J Cancer</source>
<year>2019</year>
<volume>145</volume>
<fpage>901</fpage>
<lpage>915</lpage>
<pub-id pub-id-type="pmid">30653260</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal">
<person-group><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Lorton</surname><given-names>B</given-names></name><name><surname>Gupta</surname><given-names>V</given-names></name><name><surname>Shechter</surname><given-names>D</given-names></name></person-group>
<article-title>A TGF&#x003b2;-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression</article-title>
<source>Oncogene</source>
<year>2017</year>
<volume>36</volume>
<fpage>373</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="pmid">27270440</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal">
<person-group><name><surname>Ford</surname><given-names>DJ</given-names></name><name><surname>Dingwall</surname><given-names>AK</given-names></name></person-group>
<article-title>The cancer COMPASS: navigating the functions of MLL complexes in cancer</article-title>
<source>Cancer Genet</source>
<year>2015</year>
<volume>208</volume>
<fpage>178</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="pmid">25794446</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal">
<person-group><name><surname>Godoy</surname><given-names>P</given-names></name><name><surname>Cadenas</surname><given-names>C</given-names></name><name><surname>Hellwig</surname><given-names>B</given-names></name><name><surname>Marchan</surname><given-names>R</given-names></name><name><surname>Stewart</surname><given-names>J</given-names></name><name><surname>Reif</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response</article-title>
<source>Breast Cancer</source>
<year>2014</year>
<volume>21</volume>
<fpage>491</fpage>
<lpage>499</lpage>
<pub-id pub-id-type="pmid">23001506</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal">
<person-group><name><surname>Gogiashvili</surname><given-names>M</given-names></name></person-group>
<article-title>Highlight report: Activating tumor-specific T-cells for breast cancer therapy</article-title>
<source>EXCLI J</source>
<year>2018</year>
<volume>17</volume>
<fpage>1210</fpage>
<lpage>1211</lpage>
<pub-id pub-id-type="pmid">30713484</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal">
<person-group><name><surname>Heimes</surname><given-names>AS</given-names></name><name><surname>Madjar</surname><given-names>K</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Battista</surname><given-names>MJ</given-names></name><name><surname>Almstedt</surname><given-names>K</given-names></name><name><surname>Elger</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer</article-title>
<source>Breast Cancer Res Treat</source>
<year>2017</year>
<volume>165</volume>
<fpage>293</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="pmid">28585074</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal">
<person-group><name><surname>Heimes</surname><given-names>AS</given-names></name><name><surname>Madjar</surname><given-names>K</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Battista</surname><given-names>MJ</given-names></name><name><surname>Almstedt</surname><given-names>K</given-names></name><name><surname>Gebhard</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer</article-title>
<source>J Cancer Res Clin Oncol</source>
<year>2017</year>
<volume>143</volume>
<fpage>1123</fpage>
<lpage>1131</lpage>
<pub-id pub-id-type="pmid">28251349</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal">
<person-group><name><surname>Hellwig</surname><given-names>B</given-names></name><name><surname>Madjar</surname><given-names>K</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Marchan</surname><given-names>R</given-names></name><name><surname>Cadenas</surname><given-names>C</given-names></name><name><surname>Heimes</surname><given-names>AS</given-names></name><etal/></person-group>
<article-title>Epsin family member 3 and ribosome-related genes are associated with late metastasis in estrogen receptor-positive breast cancer and long-term survival in non-small cell lung cancer using a genome-wide identification and validation strategy</article-title>
<source>PLoS One</source>
<year>2016</year>
<volume>11</volume>
<fpage>e0167585</fpage>
<pub-id pub-id-type="pmid">27926932</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal">
<person-group><name><surname>Loi</surname><given-names>S</given-names></name><name><surname>Drubay</surname><given-names>D</given-names></name><name><surname>Adams</surname><given-names>S</given-names></name><name><surname>Pruneri</surname><given-names>G</given-names></name><name><surname>Francis</surname><given-names>PA</given-names></name><name><surname>Lacroix-Triki</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Tumor-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers</article-title>
<source>J Clin Oncol</source>
<year>2019</year>
<volume>37</volume>
<fpage>559</fpage>
<lpage>569</lpage>
<pub-id pub-id-type="pmid">30650045</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal">
<person-group><name><surname>Lu</surname><given-names>K</given-names></name><name><surname>Tao</surname><given-names>H</given-names></name><name><surname>Si</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name></person-group>
<article-title>The histone H3 lysine 4 presenter WDR5 as an oncogenic protein and novel epigenetic target in cancer</article-title>
<source>Front Oncol</source>
<year>2018</year>
<volume>8</volume>
<fpage>502</fpage>
<pub-id pub-id-type="pmid">30488017</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal">
<person-group><name><surname>Macdonald</surname><given-names>JD</given-names></name><name><surname>Chacon Simon</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Shaw</surname><given-names>JG</given-names></name><name><surname>Howes</surname><given-names>JE</given-names></name><etal/></person-group>
<article-title>Discovery and optimization of salicylic acid-derived sulfonamide inhibitors of the WD repeat-containing protein 5 (WDR5)-MYC protein-protein interaction</article-title>
<source>J Med Chem</source>
<year>2019</year>
<pub-id pub-id-type="doi">10.1021/acs.jmedchem.9b01411</pub-id>
<comment>Available from: </comment><pub-id pub-id-type="doi">10.1021/acs.jmedchem.9b01411</pub-id>
</element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal">
<person-group><name><surname>Marchan</surname><given-names>R</given-names></name><name><surname>B&#x000fc;ttner</surname><given-names>B</given-names></name><name><surname>Lambert</surname><given-names>J</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Glaeser</surname><given-names>I</given-names></name><name><surname>Blaszkewicz</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Glycerol-3-phosphate acyltransferase 1 promotes tumor cell migration and poor survival in ovarian carcinoma</article-title>
<source>Cancer Res</source>
<year>2017</year>
<volume>77</volume>
<fpage>4589</fpage>
<lpage>4601</lpage>
<pub-id pub-id-type="pmid">28652252</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal">
<person-group><name><surname>Mattsson</surname><given-names>JS</given-names></name><name><surname>Bergman</surname><given-names>B</given-names></name><name><surname>Grinberg</surname><given-names>M</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Marincevic</surname><given-names>M</given-names></name><name><surname>Jirstr&#x000f6;m</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Prognostic impact of COX-2 in non-small cell lung cancer: a comprehensive compartment-specific evaluation of tumor and stromal cell expression</article-title>
<source>Cancer Lett</source>
<year>2015</year>
<volume>356</volume>
<fpage>837</fpage>
<lpage>845</lpage>
<pub-id pub-id-type="pmid">25449785</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal">
<person-group><name><surname>Punzi</surname><given-names>S</given-names></name><name><surname>Balestrieri</surname><given-names>C</given-names></name><name><surname>D'Alesio</surname><given-names>C</given-names></name><name><surname>Bossi</surname><given-names>D</given-names></name><name><surname>Dellino</surname><given-names>GI</given-names></name><name><surname>Gatti</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells</article-title>
<source>Breast Cancer Res</source>
<year>2019</year>
<volume>21</volume>
<fpage>123</fpage>
<pub-id pub-id-type="pmid">31752957</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal">
<person-group><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Hellwig</surname><given-names>B</given-names></name><name><surname>Hammad</surname><given-names>S</given-names></name><name><surname>Othman</surname><given-names>A</given-names></name><name><surname>Lohr</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin &#x003ba; C as a compatible prognostic marker in human solid tumors</article-title>
<source>Clin Cancer Res</source>
<year>2012</year>
<volume>18</volume>
<fpage>2695</fpage>
<lpage>2703</lpage>
<pub-id pub-id-type="pmid">22351685</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal">
<person-group><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Weyer-Elberich</surname><given-names>V</given-names></name><name><surname>Hengstler</surname><given-names>JG</given-names></name><name><surname>Heimes</surname><given-names>AS</given-names></name><name><surname>Almstedt</surname><given-names>K</given-names></name><name><surname>Gerhold-Ay</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population</article-title>
<source>Breast Cancer Res</source>
<year>2018</year>
<volume>20</volume>
<fpage>15</fpage>
<pub-id pub-id-type="pmid">29482642</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal">
<person-group><name><surname>Sicking</surname><given-names>I</given-names></name><name><surname>Edlund</surname><given-names>K</given-names></name><name><surname>Wesbuer</surname><given-names>E</given-names></name><name><surname>Weyer</surname><given-names>V</given-names></name><name><surname>Battista</surname><given-names>MJ</given-names></name><name><surname>Lebrecht</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Prognostic influence of pre-operative C-reactive protein in node-negative breast cancer patients</article-title>
<source>PLoS One</source>
<year>2014</year>
<volume>9</volume>
<fpage>e111306</fpage>
<pub-id pub-id-type="pmid">25340395</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal">
<person-group><name><surname>Stewart</surname><given-names>JD</given-names></name><name><surname>Marchan</surname><given-names>R</given-names></name><name><surname>Lesjak</surname><given-names>MS</given-names></name><name><surname>Lambert</surname><given-names>J</given-names></name><name><surname>Hergenroeder</surname><given-names>R</given-names></name><name><surname>Ellis</surname><given-names>JK</given-names></name><etal/></person-group>
<article-title>Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2012</year>
<volume>109</volume>
<fpage>8155</fpage>
<lpage>8160</lpage>
<pub-id pub-id-type="pmid">22570503</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal">
<person-group><name><surname>Stoeber</surname><given-names>R</given-names></name></person-group>
<article-title>Highlight report: Intratumoral metabolomic heterogeneity of breast cancer</article-title>
<source>EXCLI J</source>
<year>2017</year>
<volume>16</volume>
<fpage>1328</fpage>
<lpage>1329</lpage>
<pub-id pub-id-type="pmid">29333137</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal">
<person-group><name><surname>Tan</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Ying</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407</article-title>
<source>Cell Death Dis</source>
<year>2017</year>
<volume>8</volume>
<fpage>e2686</fpage>
<pub-id pub-id-type="pmid">28300833</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal">
<person-group><name><surname>von Minckwitz</surname><given-names>G</given-names></name><name><surname>Huang</surname><given-names>CS</given-names></name><name><surname>Mano</surname><given-names>MS</given-names></name><name><surname>Loibl</surname><given-names>S</given-names></name><name><surname>Mamounas</surname><given-names>EP</given-names></name><name><surname>Untch</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Trastuzumab Emtansine for residual invasive HER2-positive breast cancer</article-title>
<source>N Engl J Med</source>
<year>2019</year>
<volume>380</volume>
<fpage>617</fpage>
<lpage>628</lpage>
<pub-id pub-id-type="pmid">30516102</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal">
<person-group><name><surname>Wu</surname><given-names>MZ</given-names></name><name><surname>Tsai</surname><given-names>YP</given-names></name><name><surname>Yang</surname><given-names>MH</given-names></name><name><surname>Huang</surname><given-names>CH</given-names></name><name><surname>Chang</surname><given-names>SY</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><etal/></person-group>
<article-title>Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition</article-title>
<source>Mol Cell</source>
<year>2011</year>
<volume>43</volume>
<fpage>811</fpage>
<lpage>822</lpage>
<pub-id pub-id-type="pmid">21884981</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal">
<person-group><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Jin</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>F</given-names></name></person-group>
<article-title>The development of inhibitors targeting the mixed lineage leukemia 1 (MLL1)-WD repeat domain 5 protein (WDR5) protein-protein interaction</article-title>
<source>Curr Med Chem</source>
<year>2019</year>
<fpage>Epub ahead of print</fpage>
<pub-id pub-id-type="doi">10.2174/0929867326666190528080514</pub-id>
<comment>Available from: </comment><pub-id pub-id-type="doi">10.2174/0929867326666190528080514</pub-id>
</element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal">
<person-group><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Lian</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>The identification of novel small-molecule inhibitors targeting WDR5-MLL1 interaction through fluorescence polarization based high-throughput screening</article-title>
<source>Bioorg Med Chem Lett</source>
<year>2019</year>
<volume>29</volume>
<fpage>638</fpage>
<lpage>645</lpage>
<pub-id pub-id-type="pmid">30626558</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal">
<person-group><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Piribedil disrupts the MLL1-WDR5 interaction and sensitizes MLL-rearranged acute myeloid leukemia (AML) to doxorubicin-induced apoptosis</article-title>
<source>Cancer Lett</source>
<year>2018</year>
<volume>431</volume>
<fpage>150</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="pmid">29857126</pub-id></element-citation></ref></ref-list></back></article>